Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | JZMed Reports | Guide to Pharmaceutical Outsourcing in China: A Handbook for Pharmaceutical and Biotechnology Companies Planning to Outsource to China

Guide to Pharmaceutical Outsourcing in China: A Handbook for Pharmaceutical and Biotechnology Companies Planning to Outsource to China

As China has become one of the hottest areas for pharmaceutical and biopharmaceutical outsourcing, there is an urgent need for the Western pharma and biotech companies, in particular those small-sized ones who do not have sufficient internal resources to manage all steps of the outsourcing process, to have a complete collection of information with regards to the current situation and service capabilities of the Chinese pharmaceutical outsourcing service providers. This guide is thus prepared to address these issues.

The Guide provides answers to following questions:

Why must I choose China as the destination for my outsourcing activities?

Whether is it the right time to go to China for outsourcing?

Whether is the IP protection still a series issue in China?

Who are those Chinese service providers?

What can they do?

How good is each of these individual Chinese CROs?

Where are they located?

How to approach them?

What is the right approach to choose an ideal service provider?

How to ensure my outsourcing effort in China will be successful?

The Guide is concentrated on description of the current service capabilities of Chinese CROs and the step-by-step procedures of how to conduct and effectively manage the outsourcing activities in China, the two urgent issues that at present need to be addressed for pharmaceutical and biotech companies that either have potential interests or are in planning to outsource to China.

This Guide differs from any of the market research reports and/or books already published in this field. It does not intend to provide the complete information about the current development situation of the Chinese pharmaceutical industry. Instead, it focuses on the specific topics in the entire, complicated process of pharmaceutical outsourcing in China. The Guide is written based on over ten years experience of the author in the pharmaceutical outsourcing industry and on the results of a broad survey most recently conducted on the Chinese pharmaceutical outsourcing service industry.

Main features of the Guide include:

- A complete and detailed analysis of the current service capabilities of Chinese CROs in each outsourcing area and the strategies of how to choose an ideal CRO that meets outsourcing requirements.

- An in-depth and objective evaluation of the potential risks for outsourcing in China at present time and detailed comparisons of the potential risks against apparent rewards.

- A comprehensive list of suggestions of proper actions the outsourcing companies, in particular the small-sized biotech companies, should take in order to minimize the risks and maximize the benefits from their outsourcing effort in China.

- A complete collection of information of more than 60 Chinese CROs that have capabilities to conduct contract research in drug discovery and development. This information includes: the service scope/capability of each Chinese CRO, the author's comments on the strengths of their service capability, the CRO company founder's background and the year the CRO was founded, the current number of technical employees (including the approximate percentage of senior (Ph.D. level) scientists) in each CRO company, as well as the complete contact information including street and e-mail addresses, phone and fax numbers as well as websites, etc.

- Detailed comparisons between the Indian pharmaceutical outsourcing service industry and the Chinese pharmaceutical outsourcing service industry, including the strengths and weakness of each country in each service area. Based on the detailed analysis of the service features of each country, the Guide further provides the suggestions to Western companies of where to choose a suitable CRO for their outsourcing projects.

- Valuable insights into the development trend of the world pharmaceutical outsourcing industry, and, based on this trend, a brave but reasonable prediction of the future development trend of the Chinese pharmaceutical outsourcing service industry in the next 5 to 10 years.

Who should buy this report:

The Guide could serve as a useful reference book for:

Pharma/biotech companies, in particular those small to medium-sized ones who have urgent needs to outsource their R&D and/or manufacturing tasks but have limited information resources to understand the Chinese outsourcing service industry.

Pharma/biotech companies who have never conducted outsourcing activities in China before but wish to do so now and need a general guideline to help them navigate the process.

Pharma/biotech companies large or small who have had outsourcing activities in China before or presently but would like to update their knowledge about the development of this Chinese industry.

Executives in the pharmaceutical industry, biotechnology industry, financial investment industry, and even government agencies, who wish to have a complete understanding of what is really going on in the Chinese pharmaceutical industry and how this industry will likely develop in the near future.

Worldwide pharmaceutical outsourcing service companies who wish to better understand the current situation including the service capabilities of their Chinese competitors

Pharmaceutical companies and outsourcing service companies in China who wish to better understand the current situation of the world pharmaceutical outsourcing industry as well as the service capabilities of their peer competitors in order to improve their own service capabilities.

Author: Jim J. Zhang, Ph.D.

Publisher: JZMed, Inc.

Date Published: February 2008

Total Number of Pages: 180

Prices:

For single user: $2,999/PDF copy

For department licensing: $4,699 (PDF copy only)

For enterprise-wide licensing: $7,699 (PDF copy only)

Table of Contents

Price

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions